Local thrombolysis for occluded arterial grafts: is the yield worth the effort? 1994

H Lacroix, and R Suy, and A Nevelsteen, and L Verheyen, and L Stockx, and G Wilms, and R Verhaeghe
Department of Vascular Surgery, University Hospital Gasthuisberg, Leuven, Belgium.

This study reports the results and complications of local thrombolytic therapy of 50 recently occluded grafts. These occurred in 41 patients with acute severe but still reversible ischemia. The majority were infra-inguinal synthetic grafts. Thrombolysis was induced with urokinase (n = 1), streptokinase (n = 11) or alteplase (n = 38) via an intra-arterial catheter. Complete angiographical lysis was obtained in 36 grafts (72%) and partial lysis in 6 (12%). The highest lysis rate was obtained with alteplase (32/36; 89%). Complementary endovascular and/or surgical intervention was needed in 17 patients to correct an underlying stenosis and/or to save the limb. Fifteen complications occurred (30%) of which distal embolization (n = 4) and bleeding (n = 8 of which 3 fatal) were the most frequent. Six of the bleeding episodes occurred in patients on chronic aspirin intake. The late results were poor. At six months, the primary patency of successfully lysed grafts dropped to 19% and the limb salvage rate to 64%. Thrombolytic therapy is far from the ideal management of thrombosed grafts: maintenance of restored patency is the challenge.

UI MeSH Term Description Entries
D007261 Infusions, Intra-Arterial Regional infusion of drugs via an arterial catheter. Often a pump is used to impel the drug through the catheter. Used in therapy of cancer, upper gastrointestinal hemorrhage, infection, and peripheral vascular disease. Infusions, Regional Arterial,Infusions, Intra Arterial,Infusions, Intraarterial,Arterial Infusion, Intra,Arterial Infusion, Regional,Arterial Infusions, Intra,Arterial Infusions, Regional,Infusion, Intra Arterial,Infusion, Intra-Arterial,Infusion, Intraarterial,Infusion, Regional Arterial,Intra Arterial Infusion,Intra Arterial Infusions,Intra-Arterial Infusion,Intra-Arterial Infusions,Intraarterial Infusion,Intraarterial Infusions,Regional Arterial Infusion,Regional Arterial Infusions
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010959 Tissue Plasminogen Activator A proteolytic enzyme in the serine protease family found in many tissues which converts PLASMINOGEN to FIBRINOLYSIN. It has fibrin-binding activity and is immunologically different from UROKINASE-TYPE PLASMINOGEN ACTIVATOR. The primary sequence, composed of 527 amino acids, is identical in both the naturally occurring and synthetic proteases. Alteplase,Plasminogen Activator, Tissue-Type,T-Plasminogen Activator,Tissue-Type Plasminogen Activator,Actilyse,Activase,Lysatec rt-PA,TTPA,Tisokinase,Tissue Activator D-44,Lysatec rt PA,Lysatec rtPA,Plasminogen Activator, Tissue,Plasminogen Activator, Tissue Type,T Plasminogen Activator,Tissue Activator D 44,Tissue Type Plasminogen Activator
D003131 Combined Modality Therapy The treatment of a disease or condition by several different means simultaneously or sequentially. Chemoimmunotherapy, RADIOIMMUNOTHERAPY, chemoradiotherapy, cryochemotherapy, and SALVAGE THERAPY are seen most frequently, but their combinations with each other and surgery are also used. Multimodal Treatment,Therapy, Combined Modality,Combined Modality Therapies,Modality Therapies, Combined,Modality Therapy, Combined,Multimodal Treatments,Therapies, Combined Modality,Treatment, Multimodal,Treatments, Multimodal
D004617 Embolism Blocking of a blood vessel by an embolus which can be a blood clot or other undissolved material in the blood stream. Embolus,Embolisms
D005260 Female Females
D005500 Follow-Up Studies Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease. Followup Studies,Follow Up Studies,Follow-Up Study,Followup Study,Studies, Follow-Up,Studies, Followup,Study, Follow-Up,Study, Followup
D006083 Graft Occlusion, Vascular Obstruction of flow in biological or prosthetic vascular grafts. Graft Restenosis, Vascular,Vascular Graft Occlusion,Vascular Graft Restenosis,Graft Restenoses, Vascular,Occlusion, Vascular Graft,Restenosis, Vascular Graft
D006470 Hemorrhage Bleeding or escape of blood from a vessel. Bleeding,Hemorrhages

Related Publications

H Lacroix, and R Suy, and A Nevelsteen, and L Verheyen, and L Stockx, and G Wilms, and R Verhaeghe
January 1988, Cardiovascular and interventional radiology,
H Lacroix, and R Suy, and A Nevelsteen, and L Verheyen, and L Stockx, and G Wilms, and R Verhaeghe
January 1991, Seminars in thrombosis and hemostasis,
H Lacroix, and R Suy, and A Nevelsteen, and L Verheyen, and L Stockx, and G Wilms, and R Verhaeghe
July 1994, British heart journal,
H Lacroix, and R Suy, and A Nevelsteen, and L Verheyen, and L Stockx, and G Wilms, and R Verhaeghe
March 1989, Journal of vascular surgery,
H Lacroix, and R Suy, and A Nevelsteen, and L Verheyen, and L Stockx, and G Wilms, and R Verhaeghe
August 2003, Acta chirurgica Belgica,
H Lacroix, and R Suy, and A Nevelsteen, and L Verheyen, and L Stockx, and G Wilms, and R Verhaeghe
September 1986, AJR. American journal of roentgenology,
H Lacroix, and R Suy, and A Nevelsteen, and L Verheyen, and L Stockx, and G Wilms, and R Verhaeghe
May 1994, American journal of surgery,
H Lacroix, and R Suy, and A Nevelsteen, and L Verheyen, and L Stockx, and G Wilms, and R Verhaeghe
January 1992, The British journal of surgery,
H Lacroix, and R Suy, and A Nevelsteen, and L Verheyen, and L Stockx, and G Wilms, and R Verhaeghe
August 1997, Acta chirurgica Belgica,
H Lacroix, and R Suy, and A Nevelsteen, and L Verheyen, and L Stockx, and G Wilms, and R Verhaeghe
October 1994, Journal of vascular surgery,
Copied contents to your clipboard!